Stem Cell Therapy: A Promising Treatment of Parkinson's Diseases

The neurodegenerative disorder is a prolonged persistence curse and effect on economic and physical challenges in an aging world. Parkinson has come in the second category of disability disorders and associated with progressive dopaminergic neuronal degeneration with severe motor complications. It i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Humaira Ansari (Author), Shumaila Usman (Author), Syed Tousif Ahmed (Author), Shazia Hashmat (Author)
Formato: Libro
Publicado: ziauddin University, 2024-05-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2b94e56e4dbc4b4bb08522f83fb325bb
042 |a dc 
100 1 0 |a Humaira Ansari  |e author 
700 1 0 |a  Shumaila Usman  |e author 
700 1 0 |a Syed Tousif Ahmed  |e author 
700 1 0 |a Shazia Hashmat  |e author 
245 0 0 |a Stem Cell Therapy: A Promising Treatment of Parkinson's Diseases 
260 |b ziauddin University,   |c 2024-05-01T00:00:00Z. 
500 |a 10.36283/PJMD10-1/013 
500 |a 2313-7371 
500 |a 2308-2593 
520 |a The neurodegenerative disorder is a prolonged persistence curse and effect on economic and physical challenges in an aging world. Parkinson has come in the second category of disability disorders and associated with progressive dopaminergic neuronal degeneration with severe motor complications. It is an observation that gradual disease progression causes 70% degeneration of striatal dopaminergic neurons. Globally there are around 7-10 million patients with Parkinson's disease, however, there are huge efforts for therapeutic improvement. According to studies, no single molecular pathway was pointed out as a single etiology to control disease progression due to a lack of targeted therapeutic strategies. Previously implemented symptomatic treatments include L-dopa (L-3,4-dihydroxyphenylalanine), deep brain stimulation, and the surgical insertion of a medical device. This leads to dyskinesia, dystonia and a higher risk of major surgical complications respectively. However, not all the above-mentioned therapies can regenerate the dopaminergic neurons in Parkinson's disease patients. Recent advances in the field of cellular therapy have shown promising outcomes by differentiation of multipotent mesenchymal stem cells into dopaminergic neurons under the influence of a regenerative substance. In this review, we have discussed the differentiation of dopaminergic neurons by using different cell types that can be used as a cellular therapeutic approach for Parkinson's disease. The information was collected through a comprehensive search using the keywords, "Parkinson Disease, Dopamine, Brain derived neurotrophic" factor and neuron from reliable search engines, PubMed, Google Scholar and Medline reviews from the year 2010 to 2020. Keywords: Parkinson Disease; Dopamine; Brain Derived Neurotrophic Factor; Neuron. 
546 |a EN 
690 |a Biochemistry 
690 |a QD415-436 
690 |a Dentistry 
690 |a RK1-715 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Medicine (General) 
690 |a R5-920 
655 7 |a article  |2 local 
786 0 |n Pakistan Journal of Medicine and Dentistry, Vol 10, Iss 1 (2024) 
787 0 |n https://ojs.zu.edu.pk/pjmd/article/view/964 
787 0 |n https://doaj.org/toc/2313-7371 
787 0 |n https://doaj.org/toc/2308-2593 
856 4 1 |u https://doaj.org/article/2b94e56e4dbc4b4bb08522f83fb325bb  |z Connect to this object online.